Kazuma Tomizuka

USPTO Granted Patents = 29 (Patent Applications = 10)

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 5)

Average Co-Inventor Count = 4.4

ph-index = 9

Forward Citations = 436(Granted Patents)

Location History:

Kanagawa, JP (2003)
Gumma, JP (2008)
Yokohama, JP (2012)
Gunma, JP (2009 - 2016)
Takasaki, JP (2006 - 2019)
Tokyo, JP (2014 - 2020)

Company Filing History:

18 out of 272

Kyowa Hakko Kirin Co., Limited

E. R. Squibb Sons, Inc.

patents

4. 3 out of 215

Kirin Beer Kabushiki Kaisha

patents

5. 3 out of 6

Kirin Pharma Kabushiki Kaisha

patents

6. 2 out of 47

Kirin Holdings Kabushiki Kaisha

patents

7. 1 out of 42

Kirin Brewery Company, Limited

Kyowa Kirin Co., Ltd.

where one patent can have more than one assignee

Years Active: 2003-2020

Loading Chart...

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10646544 - Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled 1, Frizzled 2 or Frizzled 7 extracellular cysteine-rich domain (2020-05-12),

2. 10448622 - Human artificial chromosome containing human antibody lambda light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission (2019-10-22),

3. 10076103 - Transgenic transchromosomal rodents for making human antibodies (2018-09-18),

4. 9700594 - Pharmaceutical composition for treating bone diseases which comprises protein comprising Frizzled1, Frizzled2 or Frizzled7 extracellular cysteine-rich domain (2017-07-11),

5. 9499838 - Human artificial chromosome containing human antibody λ light chain gene and non-human animal containing the human artificial chromosome capable of genetic transmission (2016-11-22),

6. 9426970 - Transgenic transchromosomal rodents for making human antibodies (2016-08-30),

7. 8951789 - Mammalian artificial chromosome vector comprising human cytochrome P450 gene (cluster) and non-human mammalian animal retaining the same (2015-02-10),

8. 8835712 - Transgenic trasnchromosomal rodents for making human antibodies (2014-09-16),

9. 8809045 - Human artificial chromosome (HAC) vector and human cell medicine comprising same (2014-08-19),

10. 8703482 - Human artificial chromosome (HAC) vector (2014-04-22),

11. 8124406 - Method for modifying chromosomes (2012-02-28),

12. 8110671 - Isolated human chromosome 14 fragment encoding immunoglobulin genes (2012-02-07),

13. 7951381 - Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor (2011-05-31),

14. 7928285 - Method of producing xenogenous antibodies using a bovine (2011-04-19),

15. 7868223 - Method for modifying chromosomes (2011-01-11),

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about the inventor Kazuma Tomizuka.

Title: Inventor Spotlight - Kazuma Tomizuka from Takasaki, JP

Introduction: Kazuma Tomizuka is a prolific inventor based in Takasaki, JP, with an impressive portfolio of 29 patents. His groundbreaking inventions have significantly impacted the fields of pharmaceuticals and genetics.

Latest Patents:

1. Pharmaceutical composition for treating bone diseases: Tomizuka's patent involves a pharmaceutical composition aimed at treating bone diseases. It consists of a protein with specific extracellular cysteine-rich domains, enhancing bone mass, density, and strength.

2. Human artificial chromosome containing human antibody lambda light chain gene: This patent focuses on a human artificial chromosome designed for high-efficiency genetic transmission to the next generation. It includes a region with a human antibody λ light chain gene bound to a transmissible chromosome fragment in non-human animals.

Career Highlights:

Kazuma Tomizuka has worked with esteemed companies such as Kyowa Hakko Kirin Co., Limited and Medarex Inc. His tenure with these organizations has been marked by innovative contributions that have pushed the boundaries of science and technology in the pharmaceutical and biotech industries.

Collaborations:

Throughout his career, Tomizuka has collaborated closely with notable coworkers like Isao Ishida and Yoshimi Kuroiwa. Their combined expertise and dedication to cutting-edge research have led to the successful development of groundbreaking inventions and patents.

Conclusion:

In conclusion, Kazuma Tomizuka stands out as a pioneering inventor with a remarkable track record of innovation in pharmaceuticals and genetics. His patents not only showcase his technical prowess but also highlight his commitment to advancing scientific knowledge and improving healthcare outcomes dot Thank you for exploring the remarkable journey of inventor Kazuma Tomizuka with us.

This text is generated by artificial intelligence and may not be accurate.